The global clinical decision support systems market size was valued at USD 5.03 billion in 2022. It is estimated to reach USD 11.96 billion by 2031, growing at a CAGR of 10.1% during the forecast period (2023–2031). The increase in demand for quality care and technical solutions and the rise in adoption of CDSS by organizations promote market growth.
A clinical decision support system (CDSS) is a type of health information technology that offers knowledge and information tailored to a specific person to physicians, staff, patients, and other individuals to enhance health and healthcare. To enhance clinical workflow decision-making, CDSS integrates several tools. These resources include targeted patient data reports and summaries, patient data alerts and reminders for patients and healthcare providers, clinical recommendations, condition-specific order sets, documentation templates, diagnostic support, and reference data that is contextually pertinent. Robert Hayward of the Center's working definition for health evidence is as follows: "Clinical decision support systems connect health observations with health knowledge to influence clinicians' health care decisions." A crucial component of artificial intelligence in medicine is CDSSs.
| Report Metric | Details |
|---|---|
| Base Year | 2022 |
| Study Period | 2023-2031 |
| Forecast Period | 2023-2031 |
| CAGR | 10.1% |
| Market Size | USD 5.03 billion |
| Fastest Growing Market | Asia Pacific |
| Largest Market | North America |
| Report Coverage | Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends |
| Geographies Covered |
|
Providing high-quality care is an ongoing issue for the healthcare system. The population is aging quickly, resources are running out, and there aren't enough well-designed healthcare SOPs and treatment plans, among other things. Hospitals and healthcare organizations are more receptive to converting to technology-driven frameworks to meet this need. Hospitals and other healthcare organizations are integrating processes to manage time-consuming paperwork and medical and administrative employees. They make accessing a patient's clinical and administrative data simple for all departments. Additionally, hospital chains must exchange data with their branch offices to encourage the use of high-quality, interoperable solutions.
Clinical decision-making is a challenging endeavor that requires a skilled practitioner, a welcoming setting, and trustworthy informational inputs. Implementing CDSS as a supplementary tool can help healthcare entities overcome the challenges they experience in making high-quality clinical decisions. The development of CDSS has been acknowledged as a crucial instrument for overcoming obstacles in providing patients with high-quality treatment by enhancing and streamlining the quality of healthcare delivery.
CDSS is increasingly used across many healthcare operations, including diagnosis, medication prescribing, and clinical research. Numerous healthcare organizations, including those in the public and private sectors, have acknowledged the significance of CDSS. Additionally, healthcare organizations are pushing the installation and integration of EHR and CDSS, which is projected to have a favorable market impact by motivating hospitals and healthcare organizations to use such solutions. The amount of CDSS impact and how the adoption of CDSS can address various healthcare entities' issues.
Employees who are familiar with technical details are necessary to deploy CDSS effectively. The need for basic knowledge and training to operate CDSS, EHR, and other health IT software and systems has become a minor barrier to market growth. In contrast to urbanized places, it is seen that this restriction has a greater influence in isolated areas. The impact of this limitation is projected to lessen significantly throughout the forecast period, though, given the expansion in healthcare domains in terms of popularity, awareness, and adoption.
Medical records of patients might be discovered dispersed throughout hospitals in emerging economies due to a lack of adequate healthcare infrastructure. Such circumstances make it challenging for a doctor to deliver quality care and can jeopardize patient outcomes. To provide their inhabitants with improved healthcare facilities, the governments of many developing economies are making investments and starting new programs. For instance, the Ayushman Bharat initiative in India, introduced by the Union Government in 2016, focuses on primary, secondary, and tertiary care systems' healthcare and addresses preventive and health promotion. In India, public and commercial hospitals are anticipated to use CDSS tools more frequently due to this strategy.
Based on region, the global clinical decision support systems market is bifurcated into North America, Europe, Asia-Pacific, Latin America, and the Middle East and Africa.
North America is the most significant global clinical decision support systems market shareholder and is estimated to exhibit a CAGR of 7.6% over the forecast period. Its market dominance can be linked to the medical industry's rising demand for healthcare IT solutions. The market expansion in this area is also fueled by the quick development of technology and the growing significance of offering high-quality healthcare services. Market participants negotiate licensing agreements with top hospitals and healthcare organizations to increase their consumer base. One of the main forces driving the market is the rising demand for trustworthy technology solutions integrated into high-quality care.
Europe is anticipated to exhibit a CAGR of 9% over the forecast period. Over the projection period, the European CDSS market is anticipated to hold a sizeable market share. According to NCBI, using such tools in clinical care presented certain foreseeably difficult legal issues for European healthcare providers and DSS suppliers. To ensure compliance with national and European legislation and standards necessary for fair and safe patient care, DSS developers and healthcare providers collaborate. More complex AI or machine learning technologies are progressively powering more advanced versions of these products. These elements support the expansion of the world market.
Asia-Pacific has emerged as one of the fastest-growing regions in the global market. This can be ascribed to rising healthcare investment in nations like Australia, China, India, and Japan. Due to increased R&D spending by governments of key nations for boosting the penetration of information technology in the medical area, the Asia Pacific market is exhibiting great potential. The growing geriatric demographic pool is an important aspect anticipated to support the Asia Pacific market.
In Latin America, due to the rising frequency of chronic diseases, it is predicted to hold a sizable share over the projection period. WHO reports that in 2016, 62.8% of men and 59.8% of women in Latin American adults were overweight or obese. Poverty is linked to obesity, which is connected to chronic, low-grade inflammation and a risk factor for non-alcoholic fatty liver disease. Use-based systems, such as patient communication and online appointment scheduling features, accounting features, and imaging modules, are being developed by key players who offer CDSS. These can do away with the requirement for specific software for each task, lowering operating expenses while increasing the general efficacy and efficiency of clinical procedures and appointment scheduling and increasing market share.
In the Middle East and Africa, growing patient needs, better healthcare economics, and technological developments drive market expansion. Reducing inpatient treatment's high degree of unpredictability is one of the main driving forces behind its expansion.
The global clinical decision support systems market is bifurcated into product, delivery mode, application, and component.
Based on the product, the global clinical decision support systems market is bifurcated into Standalone CDSS, Integrated CPOE with CDSS, Integrated EHR with CDSS, Integrated CDSS with CPOE, HER.
The Standalone CDSS segment dominates the global market and is projected to exhibit a CAGR of 8.6% over the forecast period. With standalone, there is no coupling, making the CDS system unique from all other systems. Such systems don't need standardization, have low clinical knowledge requirements, and don't require actual patient data. Although these technologies are slow and impractical, the market is nonetheless anticipated to increase steadily during the projection period. The interoperability of some standalone solutions with reporting and EHR software is lacking. As an illustration, most CDSS for anticoagulation are stand-alone programs that do not connect to electronic health data. Additionally, incorporating massive data into current systems significantly burdens infrastructure and application maintenance. During the foreseeable period, there should be less demand for this.
Based on delivery mode, the global clinical decision support systems market is bifurcated into Web-Based Systems, Cloud Based Systems, and On-Premises Systems.
The On-Premises Systems segment owns the highest market share and is predicted to exhibit a CAGR of 8.1% over the forecast period. Large-scale healthcare organizations and multispecialty hospitals use this technology to protect patient data. Only internal users of this system can access and update the data. Due to high installation and trade expenses, they are pricey at first, but the costs are eventually recovered. Data security and a decrease in threat issues are additional benefits offered to the user, making it their first option.
Based on the application, the global clinical decision support systems market is bifurcated into Drug-Drug Interactions, Drug Allergy Alerts, Clinical Reminders, Clinical Guidelines, Drug Dosing Support, and Others.
The Drug Allergy Alerts segment dominates the global market and is projected to exhibit a CAGR of 8.6% over the forecast period. Many people have allergies to specific medicines. Therefore, having systems that send allergy notifications is essential. As a subcategory of allergies, drug allergies are on the rise. A medication error could happen while writing, dispensing, or administering a prescription. It may have negative consequences, such as giving medication to a patient with a known allergy to that substance. CPOE systems with integrated CDSS may be able to stop such medication errors and negative outcomes. The CDS system generates allergy alerts by comparing the patient's EHR data with the prescription entered by the practitioner. Additionally, it offers information about the allergy, the type of allergy that may manifest on a scale of unfavorable, severe, moderate, and mild, as well as the accessible alternative treatment.
The global clinical decision support systems market is bifurcated based on components into Hardware, Software, and Services.
The service segment owns the highest market share and is predicted to exhibit a CAGR of 8.8% over the forecast period. Maintenance of the components and their accessories is a component of CDSS services. It involves software and hardware changes, information databases, and recent medical discoveries.
